Matches in Nanopublications for { ?s ?p "DDI between Etravirine and Crizotinib - Crizotinib, when administered concomitantly with etravirine (a strong CYP3A4 inducer), may experience a decrease in serum concentration. It is recommended to avoid this combination. [drugbank_resource:DB06414_DB08865]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB06414_DB08865 label "DDI between Etravirine and Crizotinib - Crizotinib, when administered concomitantly with etravirine (a strong CYP3A4 inducer), may experience a decrease in serum concentration. It is recommended to avoid this combination. [drugbank_resource:DB06414_DB08865]" assertion.